gradalis playing hardball or business as usual, page-37

i dunno - if it doesn't have bucks directly tied to BLT in the ann then they could cure cancer and HIV using ddRNAi and at best we'd see a blip and then a retraction to the norm.

but if pfizer, oo waa, sign another $1M research licence direct with benitec then the market will go crazy crazy. silly bunch that they are.

that said, what we haven't seen in sp rises we'll get 10 fold after the first bucks do get signed, because the market will be tripping over itself once the due diligence commentary form the analysts comes out on BLT. they'll be able to factor the first deal, and then get frenzied over the massive prospects ahead.